Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review Luis Gutiérrez-Rojas; Jesús José de la Gándara Martín; Luisa García Buey; Juan I. Uriz Otano; Álvaro Mena; Carlos Roncero;

The efficiency of artificial intelligence for management and clinical decision-making in the identification of patients with hidden HCV infection (Intelligen-C strategy) José Luis Castro Urda; Marta Álvarez; Helena Cantero; Victoria Ayala; Marta Vázquez; Javier Castro; Laura Salinas-Ortega; Raquel Domínguez-Hernández;

Externalized nurse-led model for hepatitis C virus microelimination and impact of drug use profile Anna Miralpeix; Paula Ibáñez; Víctor Navarro; Patricia Colomera; Montserrat Gálvez; Zoe Mariño; Xavier Major; Joan Colom; Xavier Forns; Sabela Lens;